
Drug news
EU approves ApiFix AIS System (ApiFix) for Adolescent Idiopathic Scoliosis
ApiFix has received CE Mark approval for its ApiFix AIS correction system, a minimally invasive treatment system for Adolescent Idiopathic Scoliosis (AIS). ApiFix also reports that it has successfully completed a European pilot clinical trial with positive results.
In the ApiFix system, a small implant is attached to the center of the main spinal curvature using only two screws, resulting a 10 cm scar, compared to over 40 cm scar in the standard procedure. After recovering from surgery, which takes only about an hour, the patient undergoes physical therapy treatments. This minimizes risk, pain and scarring for the patient; and speeds recovery time. The shorter, simpler procedure costs less, as well.